BCTX Latest Press Releases

-- November 6, 2026 --

BriaCell and BriaPro Present Positive Preclinical Immunotherapy Data Across Four Posters at SITC 2026 Globe Newswire 9:00 AM

-- November 5, 2026 --

BriaCell Awarded 2026 'Immunotherapy Solution of the Year' By BioTech Breakthrough Globe Newswire 8:00 AM

-- November 3, 2026 --

BriaCell and BriaPro to Present Preclinical Anti-Cancer Activity and Immunotherapy Findings at SITC 2026 Globe Newswire 9:00 AM

-- October 23, 2026 --

BriaCell Announces ESMO 2026 Poster Highlighting Circulating Immune Biomarker Associated with Clinical Outcomes in Metastatic Breast Cancer Globe Newswire 7:30 AM

-- October 6, 2026 --

BriaCell and BriaPro to Present Four Posters at SITC 2026 Annual Meeting Globe Newswire 7:30 AM

-- September 14, 2026 --

Data Safety Monitoring Board (DSMB) Recommends Continuing BriaCell's Phase 3 Metastatic Breast Cancer Study Globe Newswire 7:30 AM

-- September 11, 2026 --

Three Nasdaq Cancer Developers Under $10 Advance Clinical Programs Globe Newswire 8:45 AM

-- September 8, 2026 --

BriaCell's Pivotal Phase 3 Metastatic Breast Cancer Study Expands to Leading Cancer Center Globe Newswire 7:30 AM

-- August 24, 2026 --

BriaCell Advances Personalized Melanoma Immunotherapy Vaccine Candidate, Bria-MEL+ Globe Newswire 7:30 AM

-- August 5, 2026 --

BriaCell Receives FDA Clearance to Initiate Bria-PROS+ Clinical Study in Prostate Cancer Globe Newswire 7:30 AM

-- July 16, 2026 --

BriaCell Opens First Canadian Site - Sunnybrook - for Pivotal Phase 3 Trial in Metastatic Breast Cancer Globe Newswire 7:30 AM

-- July 15, 2026 --

BriaCell Arranges Scalable Manufacturing with FUJIFILM Biotechnologies for Bria-IMT Globe Newswire 7:30 AM

-- July 7, 2026 --

BriaCell Engages Consulting and Branding Firms to Support Commercial and Market Access Evaluation of Bria-IMT Globe Newswire 7:30 AM

-- June 25, 2026 --

BriaCell Partners with Uneedle for Scalable Microneedle Administration of Bria-IMT Globe Newswire 7:30 AM

Market Data Delayed 15 Minutes